WaveMan · Form 4
Chevallard Daniel R. insider trades
> Search tickers & screens ⌘K
LIVE

Chevallard Daniel R. insider trades

Chevallard Daniel R. has filed 20 Form 4s with the SEC that we hold, for VIRX (CFO and COO) and LENZ Therapeutics, Inc. (LENZ) (Chief Financial Officer). Across all of them we count 4 purchases worth $164.3K and 11 sales worth $99.4K reported on Form 4. In the last 12 months: 3 purchases ($114.3K) and 0 sales ($0). The largest single trade was a purchase of 7,500 shares of LENZ Therapeutics, Inc. worth $64.3K, dated 2026-03-27. The first filing on our record is dated 2021-09-29 and the latest 2026-03-30.

VIRX

CFO and COO · 14 filings · 11 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-11-26S, sale reported on Form 43,254$15.6K2021-11-29
2021-11-29S, sale reported on Form 44,325$20.8K2021-11-29
2022-02-28S, sale reported on Form 43,998$11.1K2022-03-01
2022-05-26S, sale reported on Form 43,596$6.8K2022-05-27
2022-08-26S, sale reported on Form 43,655$14.7K2022-08-29
2022-11-28S, sale reported on Form 43,532$9.6K2022-11-29
2023-02-27S, sale reported on Form 43,599$6.0K2023-02-28
2023-05-25S, sale reported on Form 43,635$5.2K2023-05-26
2023-08-28S, sale reported on Form 43,512$5.1K2023-08-29
2023-11-28S, sale reported on Form 43,720$1.9K2023-11-28
2024-02-27S, sale reported on Form 43,405$2.5K2024-02-27

LENZ Therapeutics, Inc. (LENZ)

Chief Financial Officer · 6 filings · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-05-14P, purchase reported on Form 43,188$50.0K2024-05-15
2025-11-07P, purchase reported on Form 42,178$49.6K2025-11-07
2025-11-07P, purchase reported on Form 420$4542025-11-07
2026-03-27P, purchase reported on Form 47,500$64.3K2026-03-30
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1706176) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms